Collaboration with: Evidentic (Germany)
Since: 2019
Through this collaboration, our customers get access to advanced analytical methods for characterization of biosimilars and comparison to the originator biologics. Together, Alphalyse and Evidentic focus on solving challenges with research and development of biosimilars.
Evidentic is the first company that offers original EU-licensed drugs, based on therapeutic antibodies, for purchase in small amounts as research consumables. This makes it possible for researchers to source different batches of therapeutic antibodies as consumables – instead of buying expensive original vials.